PR96213

DUBAI, UAE, May 26, 2022 /PRNewswire=KYODO JBN/ --

The pharmaceutical group, present in 140 countries in the world, aims to raise

standard of patient healthcare across the Middle East and Africa (MEA) region

with innovative products and breakthrough research

Menarini, the leading Italian pharmaceutical group founded in 1886, today

opened its regional headquarters in Dubai Science Park as part of its goal to

expand its presence to the Middle East and Africa (MEA) region. Specializing in

pharmaceutical research and production, consumer healthcare, oncology, and

diagnostics, the Group is basing its new regional office, Menarini Middle East

and Africa, in Dubai as it acts as an ideal hub location to elevate patient

health and wellbeing in the region and to form pivotal connections with key

industry stakeholders.

The inauguration drew the participation of influential healthcare dignitaries,

most notably H.E. Dr. Amin Hussain Al Amiri, Assistant Undersecretary of Public

Health Policy and Licensing at the UAE Ministry of Health and Prevention; H.E.

Nicola Lener, Ambassador of Italy to the UAE, as well as high-level executives

from Menarini's global team, as Dr Luca Lastrucci ,Group General Manager, Dr

Ugur Bingol META President and Dr Basel Thaher Middle East Regional Head and

MEA General Manager.

Elcin Barker Ergun, CEO Menarini Group and Member of the Board of Directors,

said: "Today marks a historical moment for us as we open our regional offices

in Dubai, a key inflection point, to significantly grow our presence and

portfolio in the Middle East. As a 135 years old family owned company, we are

looking forward to serve many more patients in the Middle East in the coming

years with our unwavering commitment to Quality."

Luca Lastrucci, Group General Manager at Menarini, commented: "Today's

inauguration of our MEA headquarters in Dubai is a significant milestone for

our company as we expand our investments in the MEA region. Our presence in a

leading pharmaceutical hub like Dubai will strengthen Menarini's capabilities

and improve market access in delivering breakthrough products in the areas of

cardiovascular, gastrointestinal, and inflammatory diseases." Lastrucci added:

"The UAE government has shown unwavering support for pharmaco-economic

investments through its solid commercial infrastructure and impressive

facilities. We see this as a vital step in the right direction for Menarini and

will continue to work side-by-side with the UAE government to raise healthcare

standards and support the wellbeing of communities across the UAE and

beyond."    

Commenting on Menarini's new regional launch being perfectly aligned with the

Dubai Industrial Strategy 2030, Dr. Ali Al Sayed, Director of Pharmaceutical

Services Department at the Dubai Health Authority, said: "A defining objective

of Dubai's 2030 strategy is to be a global hub for knowledge-based, sustainable

and innovation focused businesses. As Menarini is a company with longstanding

roots based in medical research, it will be a strong contributor to this

visionary strategy.  Together, we share Dubai's overarching healthcare vision

of positioning Dubai as the leading destination for healthcare knowledge,

education and training."

Present in 140 countries with over 17,000 employees, the new Menarini regional

headquarters in Dubai will be guided by Menarini's deeply rooted values of

being patient-focused, people centered, and being committed to quality,

integrity, and responsibility. This important milestone serves as a testament

to Menarini's ongoing mission of curing diseases on a global scale and

prioritizing patient health above all else.

About Menarini

The Menarini Group is a leading international pharmaceutical and diagnostics

company, with a turnover of more than $4 billion and over 17,000 employees.

Menarini is focused on therapeutic areas with high unmet needs with products

for cardiology, oncology, pneumology, gastroenterology, infectious diseases,

diabetology, inflammation and analgesia. With 18 production sites and 9

Research and Development centers, Menarini's products are available in 140

countries worldwide. For further information, please visit www.menarini.com.

Photo - https://mma.prnewswire.com/media/1826819/Menarini_1.jpg

Photo - https://mma.prnewswire.com/media/1826820/Menarini_2.jpg

Logo - https://mma.prnewswire.com/media/652491/MENARINI_Group_Logo.jpg

Source: Menarini Industrie Farmaceutiche Riunite